Magnetic nanoparticles-based therapy for malignant mesothelioma

Area of Science:

• Oncology
• Nanomedicine
• In vivo modeling

Background:

• Malignant pleural mesothelioma (MPM) is an aggressive cancer with limited treatment options.
• Developing reliable in vivo models is crucial for studying MPM biology and testing new therapies.
• Fe3O4÷salicylic acid magnetic nanoparticles (SaMNPs) are investigated for their potential therapeutic applications.

Purpose of the Study:

• To evaluate the chick embryo chorioallantoic membrane (CAM) as an in vivo model for malignant pleural mesothelioma (MPM).
• To assess the therapeutic potential of Fe3O4÷salicylic acid magnetic nanoparticles (SaMNPs) against MPM cells.
• To investigate the antitumor effects and metastatic characteristics of human MPM xenografts on CAMs.

Main Methods:

• Implantation of human MPM xenografts onto CAMs for in vivo study.
• In vitro and in vivo testing of SaMNPs on rat and human MPM cells.
• Immunohistochemical staining (calretinin, HBME-1, cytokeratins) to characterize xenograft growth.
• Assessment of SaMNP uptake and antiproliferative effects on MPM cells.

Main Results:

• MPM xenografts grew and exhibited metastatic features on the CAM model.
• SaMNPs were specifically taken up by MPM cells.
• SaMNPs demonstrated a significant antiproliferative effect at doses >100 μg/mL.
• The CAM model proved versatile for studying MPM biology and evaluating therapeutic agents.

Conclusions:

• The chick embryo chorioallantoic membrane (CAM) is a viable in vivo model for malignant pleural mesothelioma (MPM) research.
• Fe3O4÷salicylic acid magnetic nanoparticles (SaMNPs) exhibit potent antitumor activity against both rat and human MPM cells.
• SaMNPs show promise as a novel therapeutic agent for MPM treatment, warranting further investigation.